Word: mcmasters
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Five others were in serious condition at the same hospital: James Tata, 31, of Fitchburg; John Mead, whose age and address were not known; Cole Lupien, 36, of Templeton; Gary Lusco, 44, of Winchenden; and James McMaster, 18, of Shirley. Tata and McMaster were in the hospital's burn unit...
...atoms inside. The angles at which the quantum bullets ricochet tell scientists how the target atoms are arranged. That knowledge has already led to advances in semiconductors and may someday explain the bizarre phenomenon of high-temperature superconductivity. Clifford Shull, now retired from M.I.T., and Bertram Brockhouse from McMaster University in Ontario, Canada, helped perfect neutron-scattering techniques in the 1940s and '50s. Today, nearly a half-century later, they have Nobels to show for it. Ironically, the man who did the pioneering work in the field, Shull's mentor Ernest Wollan, died in 1984. By Nobel rules, the prize...
...American and a Canadian won the Nobel Prize in Physics for developing a new way to study the building blocks of all matter -- atoms and molecules. The $930,000 physics prize will be shared by Clifford G. Shull of the Massachusetts Institute of Technology and Bertram N. Brockhouse of McMaster University in Hamilton, Ontario. Both developed a way to probe atomic structure by knocking off neutrons from particles of matter...
...Result: cell division stops, the cell begins to age rapidly, and eventually it dies. Cancer cells, in contrast, have learned to stop the ticking of the telomere clock. According to research published last week in the Proceedings of the National Academy of Sciences by Calvin Harley and colleagues at McMaster University in Hamilton, Ontario, malignant cells foil the clock by producing an enzyme -- telomerase -- that protects the length of the telomere chains. In essence, telomerase makes the cancer cell immortal...
...discovery announced last week that cancer cells rely on the enzyme telomerase to stay alive opens up a different attack strategy. The leader of that research team, Calvin Harley, has taken a leave from McMaster University to work at Geron Corp. in Menlo Park, California. The company is trying to craft a drug that will block the action of telomerase. "The cancer cell," explains Harley, "is already very old. If we can inhibit telomerase, we might cause the tumor to die after a few doublings." Even better, the fact that cancer cells produce telomerase and that normal cells (save...